GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Investments And Advances

CurveBeam AI (ASX:CVB) Investments And Advances : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Investments And Advances?

CurveBeam AI's Investments And Advances for the quarter that ended in Dec. 2023 was A$0.00 Mil.

CurveBeam AI's quarterly Investments And Advances increased from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.02 Mil) but then declined from Jun. 2023 (A$0.02 Mil) to Dec. 2023 (A$0.00 Mil).

CurveBeam AI's annual Investments And Advances stayed the same from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) but then increased from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.02 Mil).


CurveBeam AI Investments And Advances Historical Data

The historical data trend for CurveBeam AI's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Investments And Advances Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Investments And Advances
- - 0.02

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Investments And Advances - - - 0.02 -

CurveBeam AI Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines